Celltrion Healthcare Competitors and Similar CompaniesClear all
CureVac's competitors and similar companies include Amolyt Pharma and OBI Pharma.
 Amolyt Pharma Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer. | |||
Founding Date | Founding Date 2000 | Founding Date 2015 | Founding Date 2002 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Écully, FR HQ Cambridge, US | Locations TW HQ San Diego, US |
Employees | Employees 82517% decrease | Employees 373% decrease | Employees 124 |
Financial | |||
Revenue (est.) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) NT$62.7m (FY, 2024) |
Cost of goods | Cost of goods €9.7m (FY, 2024) | Cost of goods N/A | Cost of goods NT$139m (FY, 2024) |
Gross profit | Gross profit €534.4m (FY, 2024) | Gross profit N/A | Gross profit (NT$63.2m) (FY, 2024) |
Net income | Net income €162.2m (FY, 2024) | Net income N/A | Net income (NT$2.5b) (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised $ 1.1b | Total funding raised $ 93.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Amolyt Pharma
HQ
Écully, FR
Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer.
View company
OBI Pharma
HQ
TW
Employees
124
OBI Pharma (台灣浩鼎) is a bio-pharma company focused on cancer therapeutics.
View company